New York, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Programmable Infusion Pumps Market by Distribution Channel, Product, and Geography - Forecast and Analysis 2020-2024" - https://www.reportlinker.com/p05838785/?utm_source=GNW
Our study also finds the sales of programmable infusion pumps in Asia, Europe, North America, and ROW. In 2019, the large-volume infusion pumps segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing prevalence of chronic diseases and rising demand from outpatient facilities will play a significant role in the large-volume infusion pumps segment to maintain its market position. Also, our global programmable infusion pumps market report looks at factors such as increasing incidence of chronic diseases, rising number if new product launches, and demand for self-administered drug delivery in home-care settings. However, high costs associated with programmable infusion pumps, availability of alternative drug delivery methods, and frequent product recalls may hamper the growth of the programmable infusion pumps industry over the forecast period.

Global Programmable Infusion Pumps Market: Overview
Growing demand for self-administered drug delivery in home-care settings
The rise in the number of people suffering from various medical conditions including arthritis diabetes and cancer, where the timing of the medication is an important and crucial factor has spurred the demand for self-administered drug delivery systems for use in home-care settings. The development of computerized ambulatory programmable drug infusion pumps has helped in the administration of antibiotics and various other categories of drugs. Companies operating in the global programmable infusion pumps market are focusing on developing ambulatory programmable drug infusion pumps to administer medications in home-care settings. This demand for self-administered drug delivery in home-care settings will lead to the expansion of the global programmable infusion pumps market at a CAGR of almost 8% during the forecast period.
Technological advances
Programmable infusion pumps are an advanced form of traditional infusion pumps, which are integrated with security software and drug libraries to provide standardized administration of drugs and nutrients, depending on the medical requirements of patients. Most pharmaceutical and medical devices companies are focusing on incorporating advanced technology in programmable infusion pumps to enhance their effectiveness, safety, and efficiency of the medication and minimize the risk of adverse reactions due to a drug overdose or underdose. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global programmable infusion pumps market is fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading programmable infusion pumps manufacturers, that include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., Fresenius SE & Co. KGaA, ICU Medical Inc., Johnson & Johnson, Medtronic Plc, Smiths Group Plc, Terumo Corp., and Ypsomed Holding AG.
Also, the programmable infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Read the full report: https://www.reportlinker.com/p05838785/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001